…The fight against HIV/AIDS requires heavy investment of both financial and human resources. Yet with none of the governments of the countries most affected by the pandemic in a position to meet such costs help has had to come from elsewhere. For example...the GSK Foundation, has been engaged in 13 different countries…[and] 77 healthcare access projects…Boehringer-Ingehlheim laboratories are supporting a prevention programme in 50 countries against mother-to-child transmission of HIV…Merck Sharp & Dohme…have reduced by half the price of their antiretroviral drugs for developing countries…More generally, 220 businesses worldwide have come together under the aegis of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria…[also refers to Pfizer]